Chonluten.
About Chonluten
Chonluten is studied in tissue regeneration and repair research, including cell and animal models. In a 2022 cell study using human THP-1 monocyte/macrophage cells, Chonluten inhibited TNF production in vitro and increased tyrosine phosphorylation of mitogen-activated kinases — one of the few externally traceable findings for this peptide family.
Research Application
Associated with anti-inflammatory effects on bronchial tissue and monocytes, in the same application area as Bronchogen. No human clinical studies exist; the evidence remains preclinical.
Important to know
Claims circulating online are often not backed by valid clinical data. Treat all information as a starting point for your own scientific research, not as usage guidance.
Sequence and regulatory status data are based on publicly available sources and refer to the compound in general, not to a specific product.
Research Overview
Studies on regenerative peptides are mostly derived from cell culture and animal models; comprehensive clinical data is typically still limited.
- Avolio F, Martinotti S, Khavinson VK, et al. Int J Mol Sci. 2022;23(7):3607. PMID 35408963
References without a PMID can be located via the respective publisher. This overview does not claim to be exhaustive.
Similar Peptides
Question about Chonluten?
We reply personally – via email or Telegram.